Opioid Withdrawal Treatment Market size Latest Trends, Revenue Growth Rate And Application Scope

 

Opioid Withdrawal Treatment Market

Growing Awareness about Opioid Overuse to Drive Opioid Withdrawal Treatment Market

The global Opioid Withdrawal Treatment Market size is expected to exhibit a strong 10.1% CAGR over the forecast period from 2022 to 2030, according to the latest research report from Market Research Future (MRFR). The global opioid withdrawal treatment market is mainly driven by the growing opioid epidemic in North America and Europe and the increasing awareness about various treatments that can be taken to reduce opioid withdrawal symptoms. The high alertness in the U.S. and Europe with regard to the overuse of prescribed opioid drugs is likely to remain a major driver for the opioid withdrawal treatment market over the forecast period. The growing healthcare industry and the growing prescription of opioid drugs in these regions is likely to remain a key driver for the opioid withdrawal treatment market over the forecast period.

Opioids are usually prescribed for pain management and have become a widely popular class of medications due to the absence of synthetic classes of drugs to perform the same task. Usually, the healthcare industry uses a natural compound as a platform for further variations and comes up with synthetic drug formulations. However, the industry has been unable to do that with regard to opioid drugs, as mimicking the analgesic effects of natural opioids has proved too difficult. This has driven prescription figures for opioids and is likely to remain a major driver for the opioid withdrawal treatment market over the forecast period.

Competitive Analysis:

Leading players in the global opioid withdrawal treatment market include Bayer AG, F. Hoffman-La Roche Ltd., Johnson & Johnson Services, Sanofi, Novartis, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Merck & Co.

·         In August 2019, Boston Medical Center researchers found the use of naltrexone to be favorable for both mother and child when treating opioid use disorders in pregnant women.

·         In 2019, Continuum Recovery Center developed the first FDA-approved medical device for clients struggling with opioid dependency. The device is the first non-pharmaceutical, non-implantable device in the market space.

Segmentation:

The global opioid withdrawal treatment market has been segmented on the basis of drug type, distribution channel, and region.

·         By drug type, the opioid withdrawal treatment market has been segmented into nonsteroidal anti-inflammatory drugs, anti-nausea medications, analgesics, natural sleep supplements, and others.

·         On the basis of distribution channel, the market has been segmented into hospital pharmacy, retail pharmacies, and online stores.

Regional Analysis:

The Americas is likely to remain the leading regional market for opioid withdrawal treatments over the forecast period due to the growing demand for opioid withdrawal treatments in the region. According to the CDC, two thirds of the deaths attributed to drug overdoses in the U.S. in 2016 involved an opioid. This is the major driver for the opioid withdrawal treatment market in North America, as the increasing awareness about the involvement of opioids in drug overdose cases is likely to be a major driver for the opioid withdrawal treatment market over the forecast period. Increasing awareness about NSAIDs and analgesics is likely to be a major driver for the Americas market for opioid withdrawal treatment market in the Americas over the forecast period.

Increasing development of other pain management medications in North America is also likely to be a major driver for the opioid withdrawal treatment market in North America over the forecast period. The major growth driver for the opioid withdrawal treatment market has been the absence of other classes of pain medications to deal with the pain problem without using opioids. Mankind’s dependence on opioids has thus resulted in a growing demand for the development of other pain medication classes, which can deliver comparable relief without using opiates. North America is likely to be a major center for the development of these drugs in the coming years, leading to a growing demand from the opioid withdrawal treatment market over the forecast period.

Europe accounts for the second largest market for opioid withdrawal treatments and is likely to retain a considerable share in the global opioid withdrawal treatment market over the forecast period.

Related Reports: Hyperhidrosis Treatment Market Research Report - Global Forecast till 2027   

Global Healthcare Data Storage Market Research Report—Forecast till 2027

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

 

Comments

Post a Comment

Popular posts from this blog

Dry Age-Related Macular Degeneration Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Strategies

Image
  Dry Age-Related Macular Degeneration Market This degenerative eye disease is caused by the thinning of the macula and interferes with a clear vision in the elderly. The macula is part of the retina that facilitates clear vision; when this part of the eye deteriorates, it causes blurred or distorted vision. But this does not mean that the individual will lose his or her sight, only the central vision is affected by this degenerative disease, and the peripheral vision remains intact. Vision loss is slow and can be corrected using innovative ocular treatments. It has been estimated that the Dry Age-Related Macular Degeneration Market has seen a jump due to increased research in drugs, rising amount of COVID-19 cases among the old and age-restricted chronic diseases.   The dry age-related macular degeneration AMD market is expected to cross USD 15,351.07 million by 2027 at a CAGR of 8.20% during the forecast period   List of Key Companies Covered...
Read more

Cardiopulmonary Resuscitation Market: Innovations and Trends Shaping Life-Saving Techniques

  Introduction Cardiopulmonary Resuscitation (CPR) stands as a vital life-saving technique that has transformed emergency healthcare. As the cornerstone of effective response to cardiac arrest, the CPR market has been witnessing remarkable advancements driven by technology, research, and innovation. This article delves into the evolving landscape of the Cardiopulmonary Resuscitation Market, highlighting its trends, innovations, and impact on global healthcare. CPR: A Lifeline in Critical Moments Cardiopulmonary resuscitation, commonly referred to as CPR, is a crucial technique employed to sustain blood circulation and provide oxygen to the brain during cardiac arrest. It involves chest compressions and, in some cases, rescue breaths to maintain oxygen levels until professional medical assistance arrives. CPR significantly increases the chances of survival when performed promptly and correctly. Market Growth and Trends The CPR market has been experiencing steady growth due to incre...
Read more

Pain Management Devices Market Set To Exhibit Strong Growth, Valuable Research Factors and Industry Forecast to 2030

Image
  Pain Management Devices Market – Overview The Pain Management Devices Market can anticipate expansion at a rate of 7.12% from 2020 to 2030, believes MRFR (Market Research Future). Progress in technology and better research capabilities have led to the development of devices that can control pain with limited use of drugs. Focused Market reports connected to the healthcare sector among others lately have been made available by Market Research Future which publishes a report on this sector. The development of pain management devices has been useful to control pain in a wide range of ailments. The level of relief from pain that is experienced, is one of the major driving factors for the industry, as patients who use such devices are prone to chronic pain daily. Cancer patients and the geriatric population are among the major user segments for the pain management devices as medication alone may not be sufficient to provide pain relief in their situation. The industry is antici...
Read more